Grant & Licensing Opportunities In Brief
This article was originally published in The Gray Sheet
Executive Summary
NCI shortage will not affect grants: National Cancer Institute funding of research project grants (RPG) will increase slightly and remain at 46% ($2.2 bil.) of overall budget, despite funding deficit in fiscal 2005. Although the NIH institute technically received a 1.8% budget increase in FY 2005, NCI has $62 mil. less than FY 2004 largely due to continuing RPG obligations, the agency stresses in the Jan. 18 NCI Cancer Bulletin. Reductions will take place outside of RPGs, training, cooperative research groups and specialized programs of research excellence. NCI's Board of Scientific Advisors, Board of Scientific Counselors and National Cancer Advisory Board are discussing how best to manage the remaining funds and how to continue to support new research...
You may also be interested in...
Delcath Systems
National Cancer Institute Phase II study of the firm's catheter-based perfusion technology to deliver the chemotherapy drug melphalan will begin "shortly" to treat primary hepatic tumors and metastatic liver cancer originating from adenocarcinoma, neuro-endocrine or melanoma cancers. Data from 18 patients in the Phase I NCI study showed that more aggressive melphalan treatment is possible using the local delivery technique. Anti-tumor activity was achieved in 75%, or six of eight subjects with inoperable metastatic liver cancers that began as ocular melanoma, Delcath says...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.